Document is current
Any future updates will be listed below
-
Authors
You, Chongzhao https://orcid.org/0000-0002-6425-3387
Guo, Shimeng https://orcid.org/0000-0002-8086-5092
Zhang, Tianwei https://orcid.org/0000-0001-6275-3559
He, Xinheng https://orcid.org/0000-0001-7813-5480
Gao, Tianyu
Xin, Wenwen
Zhu, Zining
Lu, Yujie
Xu, Youwei https://orcid.org/0000-0001-8069-7511
Li, Zhen
Zhang, Yumu
Cheng, Xi https://orcid.org/0000-0003-3735-645X
Jiang, Yi https://orcid.org/0000-0002-0723-1413
Xie, Xin https://orcid.org/0000-0003-2314-4800
Xu, H. Eric https://orcid.org/0000-0002-6829-8144
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (32130022)
National Natural Science Foundation of China (82304579)
National Natural Science Foundation of China (32171187)
National Natural Science Foundation of China (82330113)
- License Information
-
More Information
Article History
Received: 17 February 2025
Accepted: 9 May 2025
First Online: 25 June 2025
Conflict of interest
: H.E.X. is a founder of Cascade Pharmaceutics. All the other authors declare no competing interests.
